Sandy Spring Bank’s Medpace MEDP Stock Holding History

Sandy Spring Bank’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-880	Closed	-$65K	–	935
2020 Q1	$65K	Buy	+880	New	+$76.4K	0.01%	394

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sandy Spring Bank's MEDP Position: Q2 2020 in Review

Sandy Spring Bank sold out of Medpace (MEDP) in Q2 2020, closing a stake of 880 shares — an estimated $65K sold.

Sandy Spring Bank first reported a position in MEDP in Q1 2020 and held it in 1 quarter. The position peaked at $65K in Q1 2020. 277 funds tracked by Wall St. Rank hold MEDP as of Q2 2020.

Sandy Spring Bank reported no remaining Medpace position as of Q2 2020 after selling out during the quarter.
Sandy Spring Bank sold 880 Medpace shares in Q2 2020, an estimated $65K.
Sandy Spring Bank first reported a position in Medpace in Q1 2020 and held it in 1 quarter.
Sandy Spring Bank's Medpace position peaked at $65K in Q1 2020.
277 funds tracked by Wall St. Rank held Medpace as of Q2 2020.

Based on Sandy Spring Bank's 13F filing for Q2 2020, filed 12 Aug 2020.